PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 22 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A randomized cross-over double-blind study of infusions (3 g leaves/day) found no acute or chronic effects on plasma glucose levels or glycated hemoglobin, although plasma insulin levels were lower than placebo in the diabetic group [PMID:2201413].
Aqueous leaf extracts administered to streptozotocin-induced diabetic rats reduced hyperglycemia, polyphagia, polydipsia, urine volume, and urinary excretion of glucose and urea [PMID:8205737].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26473832 (2015) — Constituents and Pharmacological Activities of Myrcia (Myrtaceae): A Review of an Aromatic and Medicinal Group of Plants. · International journal of molecular sciences
- 2.PMID: 26590699 (2016) — α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose? · Journal of pharmaceutical and biomedical analysis
- 3.PMID: 16544938 (2006) — Inhibition of thyroid peroxidase by Myrcia uniflora flavonoids. · Chemical research in toxicology
- 4.PMID: 2201413 (1990) — Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
- 5.PMID: 8205737